Visual, clinical and quality of life outcomes of a new multifocal IOL with optimized diffractive grating: a non-randomized clinical trial

Multifocal intraocular lenses (IOLs) are designed to reduce dependence on spectacles by providing multiple focal points. However, they are associated with photic phenomena such as halos and glare, and may reduce contrast sensitivity. The BIOS Trifocal is a single-piece acrylic diffractive IOL with a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMC ophthalmology 2025-02, Vol.25 (1), p.57-9, Article 57
Hauptverfasser: Lyra, João Marcelo de Almeida Gusmão, de Almeida, Mariana Silva Gois, Lira, Lucila de Albuquerque Barbosa, Dos Santos, Laís Oliveira, Dos Santos, Mateus Lins, de Miranda Coelho, Jorge Artur Peçanha
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 9
container_issue 1
container_start_page 57
container_title BMC ophthalmology
container_volume 25
creator Lyra, João Marcelo de Almeida Gusmão
de Almeida, Mariana Silva Gois
Lira, Lucila de Albuquerque Barbosa
Dos Santos, Laís Oliveira
Dos Santos, Mateus Lins
de Miranda Coelho, Jorge Artur Peçanha
description Multifocal intraocular lenses (IOLs) are designed to reduce dependence on spectacles by providing multiple focal points. However, they are associated with photic phenomena such as halos and glare, and may reduce contrast sensitivity. The BIOS Trifocal is a single-piece acrylic diffractive IOL with a closed-loop haptic design, optimized for centration and stability. It features an aspheric, aberration-neutral surface and a precisely engineered diffraction grating for effective energy distribution across multiple distances. This study aims to evaluate the visual, clinical, and quality of life outcomes of the BIOS Trifocal IOL for treatment of cataract and presbyopia. Participants who met the inclusion criteria underwent implantation of the BIOS Trifocal IOL and were assessed at 30 and 90 days post-surgery. The evaluations included measurements of patient-reported outcomes using the NEI-VFQ 25 at postoperative day 30 and uncorrected and corrected distance visual acuity and defocus curves at postoperative day 90. Additionally, intraoperative and postoperative complications were documented. Visual acuity assessments were performed under photopic conditions, with a range of defocus from + 1.5 D to -3.0 D. Significant improvements were observed in uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), and near visual acuity (UNVA) at both 30 and 90 days post-surgery (p 
doi_str_mv 10.1186/s12886-025-03878-3
format Article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11792698</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A826159302</galeid><doaj_id>oai_doaj_org_article_7110491a6fec4c1f9c445a3af5c4d7fa</doaj_id><sourcerecordid>A826159302</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3213-2106df3e48d084d9905711ab7a85c4b114e927c1997ccecbfd4ac09885b8139e3</originalsourceid><addsrcrecordid>eNpdkt9uFCEUxidGY2v1BbwwJN544SgHmBnwxjSNfzbZpDfqLWEZ2LJhhi0wbeob-NYynbrZegU5fN_vcOCrqteAPwDw9mMCwnlbY9LUmPKO1_RJdQqsg5owaJ4e7U-qFyntMCaYUf68OqFCYADSnVZ_frk0Kf8eae9Gp5VHauzRdSm5fIeCRd5Zg8KUdRhMmgsKjeYWDZPPzobZsLpco1uXr1DYZze436ZHvbM2Kp3djUHbqLIbt59mYxjrWPhhUR1a5uiUf1k9s8on8-phPat-fv3y4-J7vb78tro4X9eaEqA1Adz2lhrGe8xZXwZpOgC16RRvNNsAMCNIp0GITmujN7ZnSmPBebPhQIWhZ9Vq4fZB7eQ-ukHFOxmUk_eFELdSxey0N7KAMROgWms002CFZqxRVNnSqe-sKqzPC2s_bQbTazPmqPwj6OOT0V3JbbiRAJ0greCF8O6BEMP1ZFKWg0vaeK9GE6YkKbSUEFY-skjf_ifdhSmO5a1mVdMUFT5SbVWZwI02lMZ6hspzTlpoBMWkqMii0jGkFI093BmwnMMll3DJEi55Hy5Ji-nN8bQHy7800b-g48rD</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3165524401</pqid></control><display><type>article</type><title>Visual, clinical and quality of life outcomes of a new multifocal IOL with optimized diffractive grating: a non-randomized clinical trial</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>SpringerLink Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><source>Springer Nature OA Free Journals</source><creator>Lyra, João Marcelo de Almeida Gusmão ; de Almeida, Mariana Silva Gois ; Lira, Lucila de Albuquerque Barbosa ; Dos Santos, Laís Oliveira ; Dos Santos, Mateus Lins ; de Miranda Coelho, Jorge Artur Peçanha</creator><creatorcontrib>Lyra, João Marcelo de Almeida Gusmão ; de Almeida, Mariana Silva Gois ; Lira, Lucila de Albuquerque Barbosa ; Dos Santos, Laís Oliveira ; Dos Santos, Mateus Lins ; de Miranda Coelho, Jorge Artur Peçanha</creatorcontrib><description>Multifocal intraocular lenses (IOLs) are designed to reduce dependence on spectacles by providing multiple focal points. However, they are associated with photic phenomena such as halos and glare, and may reduce contrast sensitivity. The BIOS Trifocal is a single-piece acrylic diffractive IOL with a closed-loop haptic design, optimized for centration and stability. It features an aspheric, aberration-neutral surface and a precisely engineered diffraction grating for effective energy distribution across multiple distances. This study aims to evaluate the visual, clinical, and quality of life outcomes of the BIOS Trifocal IOL for treatment of cataract and presbyopia. Participants who met the inclusion criteria underwent implantation of the BIOS Trifocal IOL and were assessed at 30 and 90 days post-surgery. The evaluations included measurements of patient-reported outcomes using the NEI-VFQ 25 at postoperative day 30 and uncorrected and corrected distance visual acuity and defocus curves at postoperative day 90. Additionally, intraoperative and postoperative complications were documented. Visual acuity assessments were performed under photopic conditions, with a range of defocus from + 1.5 D to -3.0 D. Significant improvements were observed in uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), and near visual acuity (UNVA) at both 30 and 90 days post-surgery (p &lt; 0.001). The defocus curve demonstrated functional vision from + 1.5 D to -3.0 D, supporting the lens's efficacy for near, intermediate, and far distances. Quality of life, as assessed by the NEI-VFQ 25, showed marked improvement across all domains (p &lt; 0.05), with no significant complications directly attributable to the IOL. The BIOS Trifocal IOL presented satisfactory effectivity in the treatment of cataract and presbyopia, providing functional vision across near, intermediate and far distances and maintaining good patient satisfaction. This trial was registered at the ReBEC (Registro Brasileiro de Ensaios Clínicos - Brazilian Registry of Clinical Trials)database under the registration code RBR-772s6y at April 6th, 2020.</description><identifier>ISSN: 1471-2415</identifier><identifier>EISSN: 1471-2415</identifier><identifier>DOI: 10.1186/s12886-025-03878-3</identifier><identifier>PMID: 39901127</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Acuity ; Aged ; Cataract ; Cataracts ; Clinical trials ; Complications ; Contrast Sensitivity - physiology ; Eye ; Female ; Humans ; Intraocular lenses ; Lens Implantation, Intraocular - methods ; Lenses, Intraocular ; Male ; Middle Aged ; Multifocal Intraocular Lenses ; Multifocal IOLs ; Optics ; Patient Satisfaction ; Patients ; Phacoemulsification ; Postoperative ; Presbyopia ; Presbyopia - physiopathology ; Presbyopia - surgery ; Presbyopia correcting IOLs ; Prospective Studies ; Prosthesis Design ; Pseudophakia - physiopathology ; Quality of Life ; Questionnaires ; Refraction, Ocular - physiology ; Software ; Statistical analysis ; Surgery ; Transplants &amp; implants ; Trifocal IOLs ; Vision ; Visual acuity ; Visual Acuity - physiology</subject><ispartof>BMC ophthalmology, 2025-02, Vol.25 (1), p.57-9, Article 57</ispartof><rights>2025. The Author(s).</rights><rights>COPYRIGHT 2025 BioMed Central Ltd.</rights><rights>2025. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2025 2025</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3213-2106df3e48d084d9905711ab7a85c4b114e927c1997ccecbfd4ac09885b8139e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11792698/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11792698/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,2096,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39901127$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lyra, João Marcelo de Almeida Gusmão</creatorcontrib><creatorcontrib>de Almeida, Mariana Silva Gois</creatorcontrib><creatorcontrib>Lira, Lucila de Albuquerque Barbosa</creatorcontrib><creatorcontrib>Dos Santos, Laís Oliveira</creatorcontrib><creatorcontrib>Dos Santos, Mateus Lins</creatorcontrib><creatorcontrib>de Miranda Coelho, Jorge Artur Peçanha</creatorcontrib><title>Visual, clinical and quality of life outcomes of a new multifocal IOL with optimized diffractive grating: a non-randomized clinical trial</title><title>BMC ophthalmology</title><addtitle>BMC Ophthalmol</addtitle><description>Multifocal intraocular lenses (IOLs) are designed to reduce dependence on spectacles by providing multiple focal points. However, they are associated with photic phenomena such as halos and glare, and may reduce contrast sensitivity. The BIOS Trifocal is a single-piece acrylic diffractive IOL with a closed-loop haptic design, optimized for centration and stability. It features an aspheric, aberration-neutral surface and a precisely engineered diffraction grating for effective energy distribution across multiple distances. This study aims to evaluate the visual, clinical, and quality of life outcomes of the BIOS Trifocal IOL for treatment of cataract and presbyopia. Participants who met the inclusion criteria underwent implantation of the BIOS Trifocal IOL and were assessed at 30 and 90 days post-surgery. The evaluations included measurements of patient-reported outcomes using the NEI-VFQ 25 at postoperative day 30 and uncorrected and corrected distance visual acuity and defocus curves at postoperative day 90. Additionally, intraoperative and postoperative complications were documented. Visual acuity assessments were performed under photopic conditions, with a range of defocus from + 1.5 D to -3.0 D. Significant improvements were observed in uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), and near visual acuity (UNVA) at both 30 and 90 days post-surgery (p &lt; 0.001). The defocus curve demonstrated functional vision from + 1.5 D to -3.0 D, supporting the lens's efficacy for near, intermediate, and far distances. Quality of life, as assessed by the NEI-VFQ 25, showed marked improvement across all domains (p &lt; 0.05), with no significant complications directly attributable to the IOL. The BIOS Trifocal IOL presented satisfactory effectivity in the treatment of cataract and presbyopia, providing functional vision across near, intermediate and far distances and maintaining good patient satisfaction. This trial was registered at the ReBEC (Registro Brasileiro de Ensaios Clínicos - Brazilian Registry of Clinical Trials)database under the registration code RBR-772s6y at April 6th, 2020.</description><subject>Acuity</subject><subject>Aged</subject><subject>Cataract</subject><subject>Cataracts</subject><subject>Clinical trials</subject><subject>Complications</subject><subject>Contrast Sensitivity - physiology</subject><subject>Eye</subject><subject>Female</subject><subject>Humans</subject><subject>Intraocular lenses</subject><subject>Lens Implantation, Intraocular - methods</subject><subject>Lenses, Intraocular</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Multifocal Intraocular Lenses</subject><subject>Multifocal IOLs</subject><subject>Optics</subject><subject>Patient Satisfaction</subject><subject>Patients</subject><subject>Phacoemulsification</subject><subject>Postoperative</subject><subject>Presbyopia</subject><subject>Presbyopia - physiopathology</subject><subject>Presbyopia - surgery</subject><subject>Presbyopia correcting IOLs</subject><subject>Prospective Studies</subject><subject>Prosthesis Design</subject><subject>Pseudophakia - physiopathology</subject><subject>Quality of Life</subject><subject>Questionnaires</subject><subject>Refraction, Ocular - physiology</subject><subject>Software</subject><subject>Statistical analysis</subject><subject>Surgery</subject><subject>Transplants &amp; implants</subject><subject>Trifocal IOLs</subject><subject>Vision</subject><subject>Visual acuity</subject><subject>Visual Acuity - physiology</subject><issn>1471-2415</issn><issn>1471-2415</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2025</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><sourceid>DOA</sourceid><recordid>eNpdkt9uFCEUxidGY2v1BbwwJN544SgHmBnwxjSNfzbZpDfqLWEZ2LJhhi0wbeob-NYynbrZegU5fN_vcOCrqteAPwDw9mMCwnlbY9LUmPKO1_RJdQqsg5owaJ4e7U-qFyntMCaYUf68OqFCYADSnVZ_frk0Kf8eae9Gp5VHauzRdSm5fIeCRd5Zg8KUdRhMmgsKjeYWDZPPzobZsLpco1uXr1DYZze436ZHvbM2Kp3djUHbqLIbt59mYxjrWPhhUR1a5uiUf1k9s8on8-phPat-fv3y4-J7vb78tro4X9eaEqA1Adz2lhrGe8xZXwZpOgC16RRvNNsAMCNIp0GITmujN7ZnSmPBebPhQIWhZ9Vq4fZB7eQ-ukHFOxmUk_eFELdSxey0N7KAMROgWms002CFZqxRVNnSqe-sKqzPC2s_bQbTazPmqPwj6OOT0V3JbbiRAJ0greCF8O6BEMP1ZFKWg0vaeK9GE6YkKbSUEFY-skjf_ifdhSmO5a1mVdMUFT5SbVWZwI02lMZ6hspzTlpoBMWkqMii0jGkFI093BmwnMMll3DJEi55Hy5Ji-nN8bQHy7800b-g48rD</recordid><startdate>20250203</startdate><enddate>20250203</enddate><creator>Lyra, João Marcelo de Almeida Gusmão</creator><creator>de Almeida, Mariana Silva Gois</creator><creator>Lira, Lucila de Albuquerque Barbosa</creator><creator>Dos Santos, Laís Oliveira</creator><creator>Dos Santos, Mateus Lins</creator><creator>de Miranda Coelho, Jorge Artur Peçanha</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><general>BMC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PIMPY</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20250203</creationdate><title>Visual, clinical and quality of life outcomes of a new multifocal IOL with optimized diffractive grating: a non-randomized clinical trial</title><author>Lyra, João Marcelo de Almeida Gusmão ; de Almeida, Mariana Silva Gois ; Lira, Lucila de Albuquerque Barbosa ; Dos Santos, Laís Oliveira ; Dos Santos, Mateus Lins ; de Miranda Coelho, Jorge Artur Peçanha</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3213-2106df3e48d084d9905711ab7a85c4b114e927c1997ccecbfd4ac09885b8139e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2025</creationdate><topic>Acuity</topic><topic>Aged</topic><topic>Cataract</topic><topic>Cataracts</topic><topic>Clinical trials</topic><topic>Complications</topic><topic>Contrast Sensitivity - physiology</topic><topic>Eye</topic><topic>Female</topic><topic>Humans</topic><topic>Intraocular lenses</topic><topic>Lens Implantation, Intraocular - methods</topic><topic>Lenses, Intraocular</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Multifocal Intraocular Lenses</topic><topic>Multifocal IOLs</topic><topic>Optics</topic><topic>Patient Satisfaction</topic><topic>Patients</topic><topic>Phacoemulsification</topic><topic>Postoperative</topic><topic>Presbyopia</topic><topic>Presbyopia - physiopathology</topic><topic>Presbyopia - surgery</topic><topic>Presbyopia correcting IOLs</topic><topic>Prospective Studies</topic><topic>Prosthesis Design</topic><topic>Pseudophakia - physiopathology</topic><topic>Quality of Life</topic><topic>Questionnaires</topic><topic>Refraction, Ocular - physiology</topic><topic>Software</topic><topic>Statistical analysis</topic><topic>Surgery</topic><topic>Transplants &amp; implants</topic><topic>Trifocal IOLs</topic><topic>Vision</topic><topic>Visual acuity</topic><topic>Visual Acuity - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lyra, João Marcelo de Almeida Gusmão</creatorcontrib><creatorcontrib>de Almeida, Mariana Silva Gois</creatorcontrib><creatorcontrib>Lira, Lucila de Albuquerque Barbosa</creatorcontrib><creatorcontrib>Dos Santos, Laís Oliveira</creatorcontrib><creatorcontrib>Dos Santos, Mateus Lins</creatorcontrib><creatorcontrib>de Miranda Coelho, Jorge Artur Peçanha</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest Health &amp; Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health &amp; Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>BMC ophthalmology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lyra, João Marcelo de Almeida Gusmão</au><au>de Almeida, Mariana Silva Gois</au><au>Lira, Lucila de Albuquerque Barbosa</au><au>Dos Santos, Laís Oliveira</au><au>Dos Santos, Mateus Lins</au><au>de Miranda Coelho, Jorge Artur Peçanha</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Visual, clinical and quality of life outcomes of a new multifocal IOL with optimized diffractive grating: a non-randomized clinical trial</atitle><jtitle>BMC ophthalmology</jtitle><addtitle>BMC Ophthalmol</addtitle><date>2025-02-03</date><risdate>2025</risdate><volume>25</volume><issue>1</issue><spage>57</spage><epage>9</epage><pages>57-9</pages><artnum>57</artnum><issn>1471-2415</issn><eissn>1471-2415</eissn><abstract>Multifocal intraocular lenses (IOLs) are designed to reduce dependence on spectacles by providing multiple focal points. However, they are associated with photic phenomena such as halos and glare, and may reduce contrast sensitivity. The BIOS Trifocal is a single-piece acrylic diffractive IOL with a closed-loop haptic design, optimized for centration and stability. It features an aspheric, aberration-neutral surface and a precisely engineered diffraction grating for effective energy distribution across multiple distances. This study aims to evaluate the visual, clinical, and quality of life outcomes of the BIOS Trifocal IOL for treatment of cataract and presbyopia. Participants who met the inclusion criteria underwent implantation of the BIOS Trifocal IOL and were assessed at 30 and 90 days post-surgery. The evaluations included measurements of patient-reported outcomes using the NEI-VFQ 25 at postoperative day 30 and uncorrected and corrected distance visual acuity and defocus curves at postoperative day 90. Additionally, intraoperative and postoperative complications were documented. Visual acuity assessments were performed under photopic conditions, with a range of defocus from + 1.5 D to -3.0 D. Significant improvements were observed in uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), and near visual acuity (UNVA) at both 30 and 90 days post-surgery (p &lt; 0.001). The defocus curve demonstrated functional vision from + 1.5 D to -3.0 D, supporting the lens's efficacy for near, intermediate, and far distances. Quality of life, as assessed by the NEI-VFQ 25, showed marked improvement across all domains (p &lt; 0.05), with no significant complications directly attributable to the IOL. The BIOS Trifocal IOL presented satisfactory effectivity in the treatment of cataract and presbyopia, providing functional vision across near, intermediate and far distances and maintaining good patient satisfaction. This trial was registered at the ReBEC (Registro Brasileiro de Ensaios Clínicos - Brazilian Registry of Clinical Trials)database under the registration code RBR-772s6y at April 6th, 2020.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>39901127</pmid><doi>10.1186/s12886-025-03878-3</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1471-2415
ispartof BMC ophthalmology, 2025-02, Vol.25 (1), p.57-9, Article 57
issn 1471-2415
1471-2415
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11792698
source MEDLINE; DOAJ Directory of Open Access Journals; SpringerLink Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; PubMed Central Open Access; Springer Nature OA Free Journals
subjects Acuity
Aged
Cataract
Cataracts
Clinical trials
Complications
Contrast Sensitivity - physiology
Eye
Female
Humans
Intraocular lenses
Lens Implantation, Intraocular - methods
Lenses, Intraocular
Male
Middle Aged
Multifocal Intraocular Lenses
Multifocal IOLs
Optics
Patient Satisfaction
Patients
Phacoemulsification
Postoperative
Presbyopia
Presbyopia - physiopathology
Presbyopia - surgery
Presbyopia correcting IOLs
Prospective Studies
Prosthesis Design
Pseudophakia - physiopathology
Quality of Life
Questionnaires
Refraction, Ocular - physiology
Software
Statistical analysis
Surgery
Transplants & implants
Trifocal IOLs
Vision
Visual acuity
Visual Acuity - physiology
title Visual, clinical and quality of life outcomes of a new multifocal IOL with optimized diffractive grating: a non-randomized clinical trial
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-16T00%3A41%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Visual,%20clinical%20and%20quality%20of%20life%20outcomes%20of%20a%20new%20multifocal%20IOL%20with%20optimized%20diffractive%20grating:%20a%20non-randomized%20clinical%20trial&rft.jtitle=BMC%20ophthalmology&rft.au=Lyra,%20Jo%C3%A3o%20Marcelo%20de%20Almeida%20Gusm%C3%A3o&rft.date=2025-02-03&rft.volume=25&rft.issue=1&rft.spage=57&rft.epage=9&rft.pages=57-9&rft.artnum=57&rft.issn=1471-2415&rft.eissn=1471-2415&rft_id=info:doi/10.1186/s12886-025-03878-3&rft_dat=%3Cgale_doaj_%3EA826159302%3C/gale_doaj_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3165524401&rft_id=info:pmid/39901127&rft_galeid=A826159302&rft_doaj_id=oai_doaj_org_article_7110491a6fec4c1f9c445a3af5c4d7fa&rfr_iscdi=true